GleamWall
中文EN

VIVS VivoSim Labs, INC.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1497253 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.6%
TTM net income YoY-417.8%
TTM EPS YoY-768.6%
Revenue 3-yr CAGR-28.4%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-8,897.8%
Net margin-7,605.9%
FCF margin-7,618.5%
EBITDA margin-8,771.9%

Returns

ROE-143.5%
ROA-104.7%
ROIC (approx.)—
Asset turnover0.01x

Leverage & solvency

Liabilities / assets27.0%
Debt / equity0.00x
Current ratio3.50x
Interest coverage-1,001.00x

Cash quality & payout

Operating cash flow / net income0.99x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue63.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue$131,000$144,000
Cost of revenue$0$5,000
Gross profit$131,000$139,000
R&D expense$4.19M$5.03M
SG&A expense$7.43M$7.73M
Operating income-$11.49M-$12.62M
Interest expense$12,000$10,000
Pretax income-$13.84M-$2.49M
Income tax$2,000$2,000
Net income-$13.84M-$2.49M
EBITDA-$11.27M-$12.35M
EPS (basic)-5.35-1.70
EPS (diluted)-5.35-1.70
Weighted avg. shares (diluted)2.59M1.46M
Balance sheet
Cash & equivalents$5.02M$11.31M
Receivables$32,000$30,000
Inventory$0$0
Current assets$6.63M$12.13M
PP&E, net$206,000$419,000
Total assets$7.39M$14.65M
Current liabilities$2.79M$3.74M
Total liabilities$8.48M$4.16M
Shareholders' equity-$1.10M$10.49M
Shares outstanding2.89M1.90M
Cash flow statement
Operating cash flow-$10.83M-$9.46M
Capital expenditure$0$13,000
Free cash flow-$10.83M-$9.47M
Investing cash flow$94,000$9.03M
Financing cash flow$4.45M$8.85M
Depreciation & amortization$215,000$266,000
Stock-based compensation$303,000$532,000

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.